|
Volumn 41, Issue 3-4, 2009, Pages 174-178
|
The efficacy and safety of two fixed combinations: timolol-dorzolamide-brimonidine versus timolol-dorzolamide. A prospective, randomized, double-masked, multi-center, 6-month clinical trial.
a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;
ANTIHYPERTENSIVE AGENT;
BRIMONIDINE;
CARBONATE DEHYDRATASE INHIBITOR;
DORZOLAMIDE;
EYE DROPS;
QUINOXALINE DERIVATIVE;
SULFONAMIDE;
THIOPHENE DERIVATIVE;
TIMOLOL;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG COMBINATION;
DRUG EFFECT;
FEMALE;
FOLLOW UP;
HUMAN;
INTRAOCULAR HYPERTENSION;
INTRAOCULAR PRESSURE;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
OPEN ANGLE GLAUCOMA;
PATHOPHYSIOLOGY;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
TIME;
TREATMENT OUTCOME;
ADRENERGIC ALPHA-AGONISTS;
ANTIHYPERTENSIVE AGENTS;
CARBONIC ANHYDRASE INHIBITORS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG COMBINATIONS;
FEMALE;
FOLLOW-UP STUDIES;
GLAUCOMA, OPEN-ANGLE;
HUMANS;
INTRAOCULAR PRESSURE;
MALE;
MIDDLE AGED;
OCULAR HYPERTENSION;
OPHTHALMIC SOLUTIONS;
PROSPECTIVE STUDIES;
QUINOXALINES;
SULFONAMIDES;
THIOPHENES;
TIME FACTORS;
TIMOLOL;
TREATMENT OUTCOME;
|
EID: 77950489213
PISSN: 15304086
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (15)
|
References (0)
|